Patent ID: 8193184

Claim:
A method for the treatment of a patient for glaucoma comprising administering to said patient an effective amount of a substituted sulphonamide selected from the group consisting of (A) a sulphonanide having the general formula (I) wherein: R 1 is selected from the group consisting of CO and SO 2 , R 2 is selected from the group consisting of NH and O, R is a tertiary diC 1-4 alkylamino group, wherein alkyl moieties are the same or different, or an amino group, alkyl moieties of which form together 5, 6 and 7-membered saturated ring, or their ends are linked by heteroatom O, with the proviso that R is 4-(N,N-diethylaminoethoxy)benzyl when R 1 is SO 2 and R 2 is NH; and R is 4-[N-(morpholinopropyl)sulfamoyl]phenyl when R 1 is CO and R 2 is NH, n is a number of carbons of linking aliphatic chain, which is linear or branched, wherein n is 0, 2 or 3, and (B) physiologically acceptable salts, hydrates or solvates thereof.